Magnetic resonance perfusion diffusion mismatch and thrombolysis in acute ischaemic stroke: a systematic review of the evidence to date

Background: The mismatch between perfusion and diffusion lesions on magnetic resonance perfusion-weighted imaging (PWI)/diffusion-weighted imaging (DWI) may help identify patients for thrombolysis. Evidence underlying this hypothesis was assessed. Methods: All papers describing magnetic resonance PWI/DWI findings in patients with acute ischaemic stroke, and their functional and/or radiological outcome at 1 month, with or without thrombolysis were systematically reviewed. Results: 11 papers fulfilled the inclusion criteria. Among these, there were 5 different mismatch definitions and at least 7 different PWI methods. Only 3 papers including 61 patients with and 18 without mismatch provided data on mismatch, outcome and influence of thrombolysis. Mismatch (v no mismatch) without thrombolysis was associated with a non-significant twofold increase in the odds of infarct expansion (odds ratio (OR) 2.2, 95% confidence interval (CI) 0.34 to 14.1), which did not change with thrombolysis (OR 2.0, 95% CI 0.37 to 10.9). Half of the patients without mismatch also had infarct growth (with or without thrombolysis). No data were available on functional outcome. Conclusions: Standardised definitions of mismatch and perfusion are needed. Infarct growth may occur even in the absence of mismatch. Currently, data available on mismatch are too limited to guide thrombolysis in routine practice. More data are needed from studies including patients with and without mismatch, and randomised treatment allocation, to determine the role of mismatch.

[1]  A. Villringer,et al.  Effect of Intravenous Thrombolysis on MRI Parameters and Functional Outcome in Acute Stroke <6 Hours , 2002, Stroke.

[2]  P. Adeleine,et al.  Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator , 2004, Journal of the Neurological Sciences.

[3]  D. Le Bihan,et al.  Correlation between Diffusion- and Perfusion-Weighted MRI and Neurological Deficit Measured by the Scandinavian Stroke Scale and Barthel Index in Hyperacute Subcortical Stroke (≤6 Hours) , 2001, Cerebrovascular Diseases.

[4]  Rudolf Graf,et al.  The ischemic penumbra , 1994, Current opinion in neurology.

[5]  C. Beaulieu,et al.  Longitudinal magnetic resonance imaging study of perfusion and diffusion in stroke: Evolution of lesion volume and correlation with clinical outcome , 1999, Annals of neurology.

[6]  B. Siewert,et al.  Acute human stroke studied by whole brain echo planar diffusion‐weighted magnetic resonance imaging , 1995, Annals of neurology.

[7]  À. Rovira,et al.  Safety and Efficacy of Intravenous Tissue Plasminogen Activator Stroke Treatment in the 3- to 6-Hour Window Using Multimodal Transcranial Doppler/MRI Selection Protocol , 2005, Stroke.

[8]  J. Wardlaw,et al.  Fogging on T2-weighted MR after acute ischaemic stroke: how often might this occur and what are the implications? , 2004, Neuroradiology.

[9]  Stephen Rose,et al.  Diffusion‐ and perfusion‐weighted MRI response to thrombolysis in stroke , 2002, Annals of neurology.

[10]  Sabbir Siddique,et al.  Perfusion computed tomography: Prediction of final infarct extent and stroke outcome , 2005, Annals of neurology.

[11]  G. Schlaug,et al.  The ischemic penumbra: operationally defined by diffusion and perfusion MRI. , 1999, Neurology.

[12]  C. Weiller,et al.  Severe ADC Decreases Do Not Predict Irreversible Tissue Damage In Humans , 2002, Stroke.

[13]  P. Barber,et al.  Refining the Perfusion—Diffusion Mismatch Hypothesis , 2005, Stroke.

[14]  Steven Warach,et al.  Early magnetic resonance imaging findings in patients receiving tissue plasminogen activator predict outcome: Insights into the pathophysiology of acute stroke in the thrombolysis era , 2004, Annals of neurology.

[15]  S. Warach,et al.  The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A Phase II MRI-Based 9-Hour Window Acute Stroke Thrombolysis Trial With Intravenous Desmoteplase , 2005, Stroke.

[16]  Roland Bammer,et al.  Influence of Arterial Input Function on Hypoperfusion Volumes Measured With Perfusion-Weighted Imaging , 2003, Stroke.

[17]  P. Barber,et al.  The Use of PWI and DWI Measures in the Design of “Proof‐of‐Concept” Stroke Trials , 2004, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[18]  P. Barber,et al.  Absent middle cerebral artery flow predicts the presence and evolution of the ischemic penumbra , 1999, Neurology.

[19]  Jeffry R Alger,et al.  Perfusion-Weighted Magnetic Resonance Imaging Thresholds Identifying Core, Irreversibly Infarcted Tissue , 2003, Stroke.

[20]  W Hacke,et al.  Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral ischemia , 2001, Annals of neurology.

[21]  K. Schulz,et al.  Multiplicity in randomised trials II: subgroup and interim analyses , 2005, The Lancet.

[22]  G. Donnan,et al.  Perfusion thresholds in acute stroke thrombolysis. , 2003, Stroke.